This approach, together with the analysis of p16Ink4a and/or p21Cip1/Waf1-knockout mice, suggested that p16Ink4a and p21Cip1/Waf1 are likely to be expressed in premalignant benign tumour cells, thereby having a protective role against malignant transformation. The gene discussed is CDKN2A; the disease is neoplasm.